Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.77 USD | +13.43% | +43.74% | -58.88% |
05-10 | Annovis Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-09 | Annovis Bio, Inc. Announces Unblinding of the Buntanetap Phase III Data in Parkinson?s Disease | CI |